GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xeno Aeronautics XENO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 29 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Xeno Aeronautics

Its shares trade under the ticker XENO. It has been listed since 1 August 2006.

Xeno Transplants Corp. operates as a bio-technology research and development company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2006-08-01. The firm intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources. As at June 30, 2007, the Company does not have any material business operations. American Xeno Inc. (AXI), a bio-technology research and development company, is a wholly owned subsidiary of the Company. On January 31, 2007, AXI acquired a patent assignment from Infigen, Inc. consisting of two issued United States and seven issued international patents and multiple patent applications relating to producing pigs by cloning.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
1 Aug 2006

Leadership

Pay as last reported

  • Dr. Michael PerryChairman of the Board, since 2007
  • Elliot LebowitzPresident, Chief Executive Officer, Director, since 2007
  • Wayne SmithChief Financial Officer, Treasurer, Secretary, Director, since 2007$20,960
  • James BecknerDirector
  • Milton DatsopoulosDirector
  • Prof. David SachsDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Xeno Transplants Corp has several strengths that give it a competitive advantage:

Weaknesses

  • However, Xeno Transplants Corp also faces certain weaknesses that can hinder its growth:

Opportunities

  • Xeno Transplants Corp has opportunities to capitalize on:

Threats

  • However, there are certain threats that Xeno Transplants Corp needs to address:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.